Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
Clinical trial NCT05777174 · COMPLETED
Trial details
- NCT number
- NCT05777174
- Sponsor
- MediBeacon
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2024-04-15
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.